原著 |
|
|
|
|
非全身型幼年特发性关节炎患儿外周血T辅助细胞1/2细胞因子水平分析 |
姜丽娇1,2, 卢美萍1, 郭莉1, 吴建强1, 邹丽霞1, 徐益萍1 |
1. 浙江大学医学院附属儿童医院风湿免疫变态反应科, 浙江 杭州 310003;
2. 浙江省台州医院儿科, 浙江 临海 317000 |
|
Serum levels of Th1/Th2 cytokines in children with non-systemic juvenile idiopathic arthritis |
JIANG Lijiao1,2, LU Meiping1, GUO Li1, WU Jianqiang1, ZOU Lixia1, XU Yiping1 |
1. Department of Rheumatology Immunology & Allergy, the Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China;
2. Department of Pediatrics, Zhejiang Taizhou Hospital, Linhai 317000, Zhejiang Province, China |
[1] |
何晓琥. 幼年特发性关节炎——国际风湿病学会联盟新分类标准讨论稿[J]. 中华儿科杂志, 2002, 40(4): 65-66. HE Xiaohu. Juvenile idiopathic arthritis, new classification standard discussion of the rheumatism association international union[J]. Chinese Journal of Pediatrics, 2002, 40(4): 65-66. (in Chinese)
|
[2] |
LIN Y T,WANG C T,GERSHWIN M E,et a1.The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis[J].Autoimmun Rev,2011,10(8):482-489.
|
[3] |
NIRMALA N, GROM A, GRAM H. Biomarkers in systemic juvenile idiopathic arthritis: a comparison with biomarkers in cryopyrin-associated periodic syndromes[J]. Curr Opin Rheumatol,2014,26(5): 543-552.
|
[4] |
郭莉,卢美萍,汤永民,等. 新发活动期全身型幼年特发性关节炎血清细胞因子水平分析[J]. 中国当代儿科杂志, 2014, 16(12): 1241-1244. GUO Li, LU Meiping, TANG Yongmin, et al. Serum cytokine levels in children with newly diagnosed active systemic juvenile idiopathic arthritis[J]. Chinese Journal of Contemporary Pediatrics, 2014, 16(12): 1241-1244. (in Chinese)
|
[5] |
DOODES P D,CAO Y, HAMEL K M, et al. IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis[J]. J Immunol, 2010, 184(3):1552-1559.
|
[6] |
NIU Q, CAI B, HUANG Z C, et al. Disturbed Th17/Treg balance in patients with rheumatoid arthritis[J]. Rheumatolo Int, 2012, 32(9):2731-2736.
|
[7] |
LUBBERTS E. Role of T lymphocytes in the development of rheumatoid arthritis. Implications for treatment[J]. Curr Pharm Des, 2015, 21(2):142-146.
|
[8] |
NISHIMOTO N,KISHIMOTO T.Intedeukin 6:from bench to bedside[J].Nat Clin Pract Rheumatol, 2006, 2(11): 619-626.
|
[9] |
YOKOTA S,TANAKA T, KISHIMOTO T. Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis[J]. Ther Adv Musculoskelet Dis,2012,4(6):387-397.
|
[10] |
STAGI S, CAVALLI L, SIGNORINI C, et al. Bone mass and quality in patients with juvenile idiopathic arthritis: longitudinal evaluation of bone-mass determinants by using dual-energy X-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography[J]. Arthritis Res Ther, 2014, 16(2): R83.
|
[11] |
OSTA B, BENEDETTI G, MIOSSEC P. Classical and paradoxical effects of TNF-α on bone homeostasis[J]. Front Immunol, 2014,13(5):48.
|
[12] |
MCINNES I B, BUCKLEY C D, ISAACS J D.Cytokines in rheumatoid arthritis-shaping the immunological landscape[J]. Nat Rev Rheumatol, 2016, 12(1): 63-68.
|
[13] |
GRAVALLESE E M, GOLDRING S R. Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis[J]. Arthritis Rheum, 2000, 43(10): 2143-2151.
|
[14] |
MAKHIJA R, KINGSNORTH A N. Cytokine storm in acute pancreatitis[J]. J Hepatobiliary Pancreat Surg, 2002, 9(4): 401-410.
|
[15] |
尹薇, 丁艳, 刘凡, 等. 幼年特发性关节炎患儿基质金属蛋白酶及细胞因子的改变及意义[J].中华风湿病学杂志,2013, 17(9): 601-605. YIN Wei, DING Yan, LIU Fan, et al. Changes of matrix metalloproteinase angcytokin-es and its clinical significance in children with juvenile idiopathic arthritis[J].Chinese Journal of Rheumatology, 2013, 17(9): 601-605.(in Chinese)
|
[16] |
TRACEY D, KLARESKOG L, SASSO E H, et al. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review[J]. Pharmacol Ther, 2008, 117(2): 244-279.
|
[17] |
WEDDERBURN L R, ROBINSON N, PATEL A, et al. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis[J]. Arthritis Rheum, 2000, 43(4): 765-774.
|
[18] |
LUBBERTS E, JOOSTE L A, CHABAUD M, et al. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion[J]. J Clin Invest, 2000,105(12): 1697-1710.
|
[19] |
SABAT R, GRVTZ G, WARSZAWSKA K, et al. Biology of interleukin-10[J]. Cytokine Growth Factor Rev, 2010, 21(5):331-344.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|